312 related articles for article (PubMed ID: 17152260)
1. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
Dillner J; Andrae B; Westermark B
Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
[No Abstract] [Full Text] [Related]
2. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
Delvenne P
Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
[TBL] [Abstract][Full Text] [Related]
3. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
4. The economic impact of HPV vaccines: not just cervical cancer.
Myers ER
Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
[No Abstract] [Full Text] [Related]
5. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
6. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
7. Who should get the HPV vaccine?
Pichichero ME
J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808
[No Abstract] [Full Text] [Related]
8. [The first HPV vaccine is now available].
Kjaer SK; Olesen F; Toftager-Larsen K; Sand C; Strauss GI; Hoffmann TU; Ottesen BS
Ugeskr Laeger; 2006 Oct; 168(44):3827-8. PubMed ID: 17118245
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of HPV-associated neoplasias by vaccination - short version of the German S3 (level 3) guideline].
Gross G; Gissmann L; Hillemanns P; Ikenberg H; Kaufmann AM; Petry KU; Pfister H; Schneede P; Schneider A; Smola S;
Dtsch Med Wochenschr; 2010 May; 135(21):1083-6. PubMed ID: 20486060
[No Abstract] [Full Text] [Related]
10. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
Boot HJ; Wallenburg I; de Melker HE; Mangen MJ; Gerritsen AA; van der Maas NA; Berkhof J; Meijer CJ; Kimman TG
Vaccine; 2007 Aug; 25(33):6245-56. PubMed ID: 17630049
[TBL] [Abstract][Full Text] [Related]
11. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
Porta M; González B; Márquez S; Artazcoz L
J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949
[No Abstract] [Full Text] [Related]
12. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
13. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
[TBL] [Abstract][Full Text] [Related]
14. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
15. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
17. Healthcare spending in the case of a HPV16/18 population-wide vaccination programme.
Vanagas G; Padaiga Z
Scand J Public Health; 2012 Jul; 40(5):406-11. PubMed ID: 22821227
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
Saslow D; Wheeler CM
Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
[TBL] [Abstract][Full Text] [Related]
19. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
20. Prevention of cervical cancer through vaccination of adolescents.
Pichichero ME
Clin Pediatr (Phila); 2006 Jun; 45(5):393-8. PubMed ID: 16891270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
